BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 18588472)

  • 1. Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan.
    Tsubouchi M; Morishita R; Tabata Y; Matsui S; Kawakami K
    Regen Med; 2008 Jul; 3(4):497-504. PubMed ID: 18588472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strengthened ties between industry and academia are historical, productive, and crucial.
    Haller JA
    Surv Ophthalmol; 2014; 59(3):348-53. PubMed ID: 24656436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At issue: A model for academic/industry collaboration.
    Carpenter WT; Koenig JI; Bilbe G; Bischoff S
    Schizophr Bull; 2004; 30(4):997-1004. PubMed ID: 15954203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 6. Leveraging the synergy between industry and academia.
    Bradley WG
    J Am Coll Radiol; 2005 Nov; 2(11):879-82. PubMed ID: 17411959
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationships between academic institutions and industry in the life sciences--an industry survey.
    Blumenthal D; Causino N; Campbell E; Louis KS
    N Engl J Med; 1996 Feb; 334(6):368-73. PubMed ID: 8538709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Academic medical centers write their own rules.
    Freischlag JA
    J Vasc Surg; 2011 Sep; 54(3 Suppl):19S-21S. PubMed ID: 21872110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry has undue influence on academic collaboration and safeguards need strengthening: white coat… which hat.
    Harbin T
    Surv Ophthalmol; 2014; 59(3):346-8. PubMed ID: 24508214
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical implications of for-profit corporate sponsorship of research.
    Cichy KA
    SRA J; 1990; 22(1):23-7. PubMed ID: 16047436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the clinical application of regenerative medicine products in Japan.
    Tsubouchi M; Matsui S; Banno Y; Kurokawa K; Kawakami K
    Health Policy; 2008 Oct; 88(1):62-72. PubMed ID: 18395290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. University - industry collaborations: models, drivers and cultures.
    Ehrismann D; Patel D
    Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborating with industry: choices for Australian medicine and universities.
    Moses H; Perumpanani A; Nicholson J
    Med J Aust; 2002 Jun; 176(11):543-6. PubMed ID: 12064987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflict of interest and the Society for Vascular Surgery.
    Elliott BM;
    J Vasc Surg; 2011 Sep; 54(3 Suppl):3S-11S. PubMed ID: 21872107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia].
    Iida K; Yano T; Ikemori M; Ishida T; Nishimura N
    Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New paradigms for physician-industry relations: overview and application for SVS members.
    Singh N; Bush R; Dalsing M; Shortell CK
    J Vasc Surg; 2011 Sep; 54(3 Suppl):26S-30S. PubMed ID: 21872112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Academia-industry Cooperation in the Medical Field: Matching Opportunities in Japan.
    Tsuruya N; Kawashima T; Shiozuka M; Nakanishi Y; Sugiyama D
    Clin Ther; 2018 Nov; 40(11):1807-1812. PubMed ID: 30415863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Collaboration between academia and companies].
    Ueda M
    Nihon Rinsho; 2008 May; 66(5):997-1002. PubMed ID: 18464523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry and the profession of medicine: balancing appropriate relationships with the need for innovation.
    Lewin J; Arend TE
    J Vasc Surg; 2011 Sep; 54(3 Suppl):47S-9S. PubMed ID: 21872116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.